VEA
DNTH icon

Virtus ETF Advisers’s Dianthus Therapeutics DNTH Stock Holding History

Virtus ETF Advisers’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,025
Closed -$65.9K – 528
2024
Q4 		$65.9K Sell
3,025
-397
-12% -$10.2K 0.03% 413
2024
Q3 		$93.7K Buy
3,422
+64
+2% +$1.78K 0.04% 386
2024
Q2 		$86.9K Buy
+3,358
New +$80.7K 0.04% 375
2021
Q4 		– Sell
-1,169
Closed -$136K – 385
2021
Q3 		$136K Sell
1,169
-61
-5% -$7.11K 0.06% 356
2021
Q2 		$192K Buy
+1,230
New +$226K 0.08% 366
2019
Q4 		– Sell
-1,100
Closed -$181K – 469
2019
Q3 		$181K Sell
1,100
-61
-5% -$11.6K 0.04% 263
2019
Q2 		$274K Buy
+1,161
New +$287K 0.06% 257

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return